Abstract:The translocation t(8;21) (q22;q22) frequently associated with additional chromosomal aberrations is one of the most recurrent chromosomal abnormalities in AML. Clinically, this type of AML usually shows some specific characteristics and has a good response to chemotherapy with a high remission rate and a relatively long median survival.On the other hand, some reports also showed poor prognosis in AML patients with t(8;21 ) , and the associated bad prognosis factors have not been strongly established to date. To investigate this issue and to further identify the related characteristics of t(8 ;21 ) AML in China, 75 Chinese AML patients with t(8 ;21 ) were retrospectively analyzed. They comprised 68 cases of M2, five of M4 and two of M5 according to FAB classification. The results indicated that Auer rods were observed in 39 patients (52%) and marrow eosinophilia was detected in only 5 patients (6.7%). These patients showed high level of HLA-DR and CD34 expression, while CD19 was detected in only 13 patients (20.9%). Cytogenetically, 62.5 % cases had additional chromosomal abnormalities, and the main associated recurrent additional abnormalities were loss of a sex chromosome (LOS), trisomy 4, del (9q) and trisomy 8. After conventional induction therapy, 62 patients attained complete remission (CR) resulting in the CR rate 82.7%. With a follow-up of 1 to 96 months, 19 cases relapsed at a median time of 10.5 months (range 3 to 42 months). The median overall survival was 20 months, and the estimated 5-year overall survival (OS) rate was 32.3%. In multivariate analyses of prognostic factors,karyotype, extramedullary leukemia, age and post-remission therapy were of prognostic value for OS. Patients with additional chromosomal anomalies had shorter survival compared to those with t(8 ;21 ) only (P = 0.019), no matter which kind of additional karyotype it was. Extramedullary leukemia was an adverse prognostic factor ( P = 0. 012). Patients aged 15 years or less had a longer survival than those aged more than 15 years (P =0.045). Patients accepted HSCT in post-remission therapy had better outcome compared to those with chemotherapy only. It is concluded that Chinese AML patients with t(8 ;21 ) had some different characteristics as compared with patients from other countries, a relatively poor outcome was observed in our patients, especially in those with extramedullary leukemia or additional chromosomal abnormalities. HSCT should be recommended to t(8 ;21 ) AML in China, especially to those with adverse prognostic factors.

[Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients].

Clinical analysis on 15 acute myeloid leukemia patients with 11p15 abnormalities

Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 1

[Clinical and Cytogenetics Studies on Acute Myeloid Leukemia with Abnormality of Chromosome 11].

Clinical Analysis of 24 Cases of Acute Myeloid Leukemia with 3q Abnormalities

Unusual Findings Of Acute Myeloid Leukemia With Inv(3)(Q21q26.2) Or T(3;3)(Q21;Q26.2): A Multicenter Study

Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A

Retrospective Analysis of 59 Cases Flt3-Itd Mutation Positive Acute Myeloid Leukemia

[Analysis of Age-Specific Cytogenetic Changes among 515 Patients Withacute Myeloid Leukemia].

11q23 abnormalities in adult Chinese patients with hematological malignancies

[Clinical Analysis of Myeloid Neoplasms with T (3;21) (Q26;q22)].

[Clinical and laboratory studies of 11 acute myeloid leukemia patients with t(7;11) (p15;p15) translocation].

Characteristics of 11 Patients with Acute Myeloid Leukemia Accompanied with Karyotype Aberration T(6;9)

Characteristics and Prognostic Factors of Acute Myeloid Leukemia with T( 8 ;21 ) ( Q22; Q22)

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors

Clinical Characteristics of Acute Myeloid Leukemia with T(16;21)(p11;q22):Nine Cases Report and Literature Review

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study

Favorable Outcome Of Allogenic Stem Cell Transplant In Patients With Acute Myeloid Leukemia Carrying T(6;9)(P22;Q34) / Dek-Nup214 Rearrangement

[Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].

Clinical and Laboratory Studies of 17 Patients with Acute Myeloid Leukemia Harboring T(7;11)(p15;p15) Translocation

Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study